Condition: Optic Neuropathy · Glaucoma · Sponsor: Stanford University
The purpose of the study is to evaluate the neuroprotective efficacy of hyperbaric oxygen for the treatment in patients with optic neuropathy.
This description comes directly from the study's public registry record.
Zac Wennberg Smith · 6504975942 · zacwenn@stanford.edu
Always discuss trial participation with your own doctor first.
| Byers Eye Institute | Palo Alto, California, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06128720